Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Regeneron Pharmaceuticals    REGN

REGENERON PHARMACEUTICALS

(REGN)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Regeneron Pharmaceuticals
Regeneron Pharmaceuticals specializes in research, development, producing, and selling drugs used in treating ophthalmologic and inflammatory diseases and cancers. Sales break down by activity as follows:

- sales of products (61.2%);

- supply of collaborative services (32.6%): working with Sanofi (50.8% of sales) and Bayer (49.2%);

- sales of technology licenses (6.2%). The group also provides subcontracting research services.

At the end of 2018, the group had a portfolio of 21 products in clinical development.

Number of employees : 7 400 people.
Sales per Businesses
20172018Delta
USD (in Million)%USD (in Million)%
Eylea3,70263%4.080.1% -99.89%
Bayer Collaboration938.1016%1.080% -99.89%
Sanofi Collaboration877.2014.9%1.110% -99.87%
Other338.505.8%0.4170% -99.88%
Arcalyst16.500.3%0.0150% -99.91%
Libtayo--0.0150%-
Sales per Regions
20172018Delta
USD (in Million)%USD (in Million)%
United States, European Union, Japan5,872100%6,711100% +14.28%
Managers
NameAgeSinceTitle
Leonard Schleifer661988Co-President, Chief Executive Officer & Director
George Damis Yancopoulos MD, PhD591989Co-President, Director & Chief Scientific Officer
P. Vagelos891995Chairman
Robert E. Landry552013Chief Financial Officer & Senior VP-Finance
Michael S. Brown, MD771991Independent Director
Joseph L. Goldstein, MD781991Independent Director
George L. Sing, MBA691988Independent Director
Arthur Frederick Ryan762003Independent Director
Christine A. Poon, MBA662010Independent Director
Marc Tessier-Lavigne, PhD592011Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Stock A 1 111,355,856 80,949,390 72.7% 3,990,021 3.6% 71.5%
Stock B 10 1,911,354 0 0.0% 0 0.0%
Shareholders
NameEquities%
Sanofi 23,654,384 22.2%
Capital Research & Management Co. (World Investors) 6,384,323 6.00%
The Vanguard Group, Inc. 5,633,223 5.30%
Fidelity Management & Research Co. 4,858,102 4.57%
BlackRock Fund Advisors 4,252,162 4.00%
Wellington Management Co. LLP 4,076,411 3.83%
Loomis, Sayles & Co. LP 3,346,280 3.15%
SSgA Funds Management, Inc. 3,233,221 3.04%
Harris Associates LP 3,173,644 2.98%
Sands Capital Management LLC 2,177,393 2.05%
Holdings
NameEquities%Valuation
Intellia Therapeutics Inc (NTLA) 2,777,7776.40%37,916,656 USD
Markets and indexes
- Nasdaq Stock Market
- Nasdaq Global Select Market
- Nasdaq 100 / SP 500
Stock Exchange Codes
- Bloomberg Code :  
- Reuters Code :  REGN.O
- Datastream Code :  
Company contact information
Regeneron Pharmaceuticals
777 Road Old Saw Mill River
NY 10591 Tarrytown, New York
États-Unis (les)

Phone : +1 (914) 847 7000
Fax : +1
Internet : http://www.regeneron.com
Sector Bio Therapeutic Drugs
Connections : Regeneron Pharmaceuticals
Cold Spring Harbor Laboratory, Inc.
Bay Area Council Economic Institute
Trustees of The University of Pennsylvania
University of Pennsylvania
Citizens Bank, NA (Providence, Rhode Island)
Manufacturing Services, Inc. (Washington)
The University of Texas Southwestern Medical Center
The Donald Danforth Plant Science Center
National Academy of Medicine of United States
American Academy of Arts & Sciences
American Philosophical Society
The International Biomedical Research Alliance
Lancet Capital Partners LLC
National Association of Corporate Directors
Citizens Bank of Pennsylvania
The Prudential Insurance Company of America, Inc.
New Jersey Performing Arts Center
Stanford University
Crane Group Co.
The Rockefeller Archive Center
National Math & Science Initiative, Inc.
The Prudential Variable Contract Real Property Account
The American Association of Arts & Sciences
The Rockefeller University
Howard Hughes Medical Institute, Inc.
Federal Reserve Bank of New York
The Cooper Institute
Stanford Alumni Association
Regeneron Research Laboratories